Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid Leukemia

SIMPLE SUMMARY: Acute myeloid leukemia (AML) is a predominately fatal blood cancer. For a period of forty years, treatment options for AML remained relatively stagnant. Recently, multiple new agents have been approved. In this review, we discuss considerations surrounding the use of these newly appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadmehrabi, Khashayar, Haque, Ali R., Aleem, Ahmed, Griffiths, Elizabeth A., Roloff, Gregory W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471378/
https://www.ncbi.nlm.nih.gov/pubmed/34572873
http://dx.doi.org/10.3390/cancers13184646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471378/
https://www.ncbi.nlm.nih.gov/pubmed/34572873
http://dx.doi.org/10.3390/cancers13184646

Ejemplares similares